Simplex Trading
ZYME icon

Simplex Trading’s Zymeworks ZYME Stock Holding History

Simplex Trading’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.5K Sell
1,336
-46,704
-97% -$1.11M ﹤0.01% 6278
2025
Q4 		$1.26M Buy
48,040
+19,279
+67% +$421K ﹤0.01% 2400
2025
Q3 		$491K Buy
28,761
+22,316
+346% +$319K ﹤0.01% 3845
2025
Q2 		$80K Buy
6,445
+2,277
+55% +$27.1K ﹤0.01% 5456
2025
Q1 		$49K Buy
4,168
+3,081
+283% +$42K ﹤0.01% 5796
2024
Q4 		$15K Sell
1,087
-443
-29% -$6.2K ﹤0.01% 6917
2024
Q3 		$19K Sell
1,530
-10,581
-87% -$115K ﹤0.01% 6727
2024
Q2 		$103K Buy
12,111
+8,965
+285% +$79.8K ﹤0.01% 5344
2024
Q1 		$33K Buy
+3,146
New +$34.9K ﹤0.01% 6680
2023
Q4 		– Sell
-11,143
Closed -$88.8K – 10013
2023
Q3 		$70K Sell
11,143
-25,881
-70% -$191K ﹤0.01% 5483
2023
Q2 		$319K Buy
37,024
+36,130
+4,041% +$323K ﹤0.01% 3767
2023
Q1 		$8K Sell
894
-47,298
-98% -$412K ﹤0.01% 7759
2022
Q4 		$378K Buy
48,192
+13,122
+37% +$92.2K ﹤0.01% 3483
2022
Q3 		$215K Sell
35,070
-17,288
-33% -$104K ﹤0.01% 4516
2022
Q2 		$277K Buy
52,358
+11,514
+28% +$69.6K ﹤0.01% 4194
2022
Q1 		$267K Buy
+40,844
New +$364K ﹤0.01% 4713
2021
Q4 		– Sell
-1,306
Closed -$27.2K – 11623
2021
Q3 		$48K Sell
1,306
-343
-21% -$11.4K ﹤0.01% 7556
2021
Q2 		$57K Sell
1,649
-3,826
-70% -$121K ﹤0.01% 7490
2021
Q1 		$172K Buy
5,475
+3,434
+168% +$140K ﹤0.01% 4979
2020
Q4 		$96K Buy
+2,041
New +$94.8K ﹤0.01% 5477
2020
Q1 		– Sell
-39,379
Closed -$1.61M – 8399
2019
Q4 		$1.79M Buy
39,379
+23,547
+149% +$856K ﹤0.01% 1576
2019
Q3 		$392K Buy
15,832
+3,391
+27% +$85K ﹤0.01% 2859
2019
Q2 		$273K Buy
12,441
+11,895
+2,179% +$218K ﹤0.01% 3170
2019
Q1 		$8K Buy
546
+394
+259% +$6.11K ﹤0.01% 6297
2018
Q4 		$2K Buy
+152
New +$1.99K ﹤0.01% 6632

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Simplex Trading's ZYME Position: Q1 2026 in Review

Simplex Trading reduced its Zymeworks (ZYME) stake by 97% in Q1 2026, selling an estimated $1.11M and leaving 1,336 shares worth $33.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6278.

Simplex Trading first reported a position in ZYME in Q4 2018 and has held it in 25 quarters since. The position peaked at $1.79M in Q4 2019. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Simplex Trading held 1,336 shares of Zymeworks worth $33.5K as of Q1 2026.
  • Simplex Trading sold 46,704 Zymeworks shares in Q1 2026, an estimated $1.11M.
  • Zymeworks made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6278 holding.
  • Simplex Trading first reported a position in Zymeworks in Q4 2018 and has held it in 25 quarters since.
  • Simplex Trading's Zymeworks position peaked at $1.79M in Q4 2019.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.